Tesla (TSLA) Terafab plans point to inevitable capital raise — its first since 2020
Tesla's new "Terafab" semiconductor project is estimated to cost between $25 and $40 billion, a massive investment compared to the company's $6.2 billion in free cash flow last year. This financial pressure makes it highly likely Tesla will need to raise capital through a stock offering, which would be its first since 2020. For owners and enthusiasts, this signals a major strategic push into chip manufacturing but also introduces financial risk and potential shareholder dilution.